DOK Plus Tablets

Manufacturer
medsource pharmaceuticals
Effective date
2018-12-26
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 00:39:20

Label at a glance#

ProductSenna/Docusate Sodium
Active ingredientSENNOSIDES, DOCUSATE SODIUM
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients (in each tablet)

Docusate Sodium 50 mg

Sennosides 8.6 mg

OTC - PURPOSE SECTION

Purpose
Stool Softener
Stimulant Laxative

INDICATIONS & USAGE SECTION

Uses relieves occasional constipation (irregularity). This product generally produces a bowel movement in 6 to 12 hours.

WARNINGS SECTION

Warnings

Ask a doctor before use if you have

  • Stomach pain
  • Nausea
  • Vomiting
  • A sudden change in bowel habits that lasts over a period of 2 weeks.

DO NOT USE

Laxative products for longer than 1 week unless directed by a doctor

If you are presently taking mineral oil, unless directed by a doctor

Ask Doctor/Pharmacist

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are presently taking mineral oil.

DOSAGE & ADMINISTRATION SECTION

Take only by mouth. Doses may be taken as a single daily dose, preferably in the evening, or in divided dose.

Age

Dosage

Adults and children

12 years of age and older

Take 2-4 tablets daily

Children 6 to under 12 years

Take 1-2 tablets daily

Children 2 to 6 years

Take up to 1 tablet daily

Children under 2 years

Do not use

Generic Section

SPL UNCLASSIFIED SECTION

Other information

  • Each tablet contains: sodium 6 mg/tablet VERY LOW SODIUM
  • Each tablet contains: calcium 20 mg/tablet.
  • Store at 20° - 25°C (68° -77°F); excursions permitted to 15°-30° (59°-86°F). [See USP Controlled Room Temperature]

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Carnauba Wax, Colloidal Silicon Dioxide, Croscarmellose Sodium, Dibasic Calcium Phosphate Dihydrate, FD&C red #40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, tapioca starch*, tartaric acie*, and titanium dioxide. *may contain these ingredients.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Questions

OTC - QUESTIONS SECTION

Questions? To Report Serious Adverse Effects Call: (800)616-2471

Distributed By:

Major® Pharmaceuticals

17177 N Laurel Park Dr., Suite 233

Livonia, MI 48152 USA

LHC51790417

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdppdp

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
45865-913-302025-02-20C16284748780-12cef2736-89c0-d83d-e063-dadaa90ab31fDOK Plus Tablets
45865-913-302025-01-30C16284748780-12cef2736-89c0-d83d-e063-dadaa90ab31fDOK Plus Tablets

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0904-5643-60EA - Each0904-5643672627f1-a8ac-46c7-b78a-454c6773bfdf12013-02-11
0904-5643-61EA - Each0904-56434c34882b-7edf-4eca-adef-036c1f6224c312013-02-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
45865-91345865-913-30
0904-5643

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2e97c0ab-53cc-d988-e063-6394a90a9d847df0e98a-07c5-94d8-e053-2a91aa0ab2272025-02-20WarningsExact identifier
spl set id: 7df0e98a-07c5-94d8-e053-2a91aa0ab227

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.